Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: Comparison of RNA levels and viral inhibition

Antisense and Nucleic Acid Drug Development

Volumn 6, Issue 1, 2009, Pages 17-24

  Zhou, C ^a   Bahner, I ^a   Rossi, J J ^b   Kohn, D B ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; RNA;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; RNA CONFORMATION; T LYMPHOCYTE; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029953286     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1996.6.17     Document Type: Article

References (11)

1. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
2. DROPULIC, B., LIN, N.H., MARTIN, M.A., and JEANG, K.T. (1992). Functional characterization of a U5 ribozyme: Intracellular suppression of human immunodeficiency virus type 1 expression. J. Virol. 66, 1432-1441.
3. LEE, S.W., GALLARDO, H.F., GILBOA, E., and SMITH, C. (1994). Inhibition of human immunodeficiency virus type 1 in human T-cells by a potent RRE decoy comprised of the 13-nucleotide minimal revbinding domain. J. Virol. 68, 8254-8264.
4. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell Biol. 6, 2895-2902.
5. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-990.
6. SARVER, N., CANTIN, E.M., CHANG, P.S., ZAIA, J.A., LADNE, P.A., STEPHENS, D.A., and ROSSI, J.J. (1990). Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225.
7. SULLENGER, B.A., and CECH, T.R. (1993). Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 262, 1566-1569.
8. SULLENGER, B.A., GALLARDO, H.F., UNGERS, G.E., and GILBOA, E. (1990a). Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63, 601-608.
9. SULLENGER, B.A., LEE, T.C., SMITH, C.A., UNGERS, G.E., and GILBOA, E. (1990b). Expression of chimeric tRNA-driven antisense transcripts render NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol. Cell Biol. 10, 6512-6523.
10. WEERASINGHE, M., LIEM, S.E., ASAD, S., READ, S.E., and JOSHI, S. (1991). Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. J. Virol. 65, 5531-5534.
11. ZHOU, C., BAHNER, I., LARSON, G., ZAIA, J.A., ROSSI, J.J., and KOHN, D.B. (1994). Anti-HIV-1 hammerhead ribozymes transduced by retroviral vectors inhibit HIV-1 replication in human T lymphocytes. Gene 149, 33-39.